Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001509322-16-000004
Filing Date
2016-12-06
Accepted
2016-12-06 16:03:04
Documents
1
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1474
  Complete submission text file 0001509322-16-000004.txt   3046
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O HEDGEPATH PHARMACEUTICALS, INC. 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address
Martin Robert Daniel (Reporting) CIK: 0001509322 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 162036345